A phase I clinical trial showed diffuse, large B-cell lymphomas resistant to chemotherapy can be reprogrammed to respond to treatment using the drug azacitidine, according to a study published in Cancer Discovery , a journal of the American Association for Cancer Research.
http://medicalxpress.com/news/2013-08-reprogrammed-treatment-resistant-lymphomas-cancer-drugs.html
http://medicalxpress.com/news/2013-08-reprogrammed-treatment-resistant-lymphomas-cancer-drugs.html
No comments:
Post a Comment